HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter A Andreasen Selected Research

Peter A Andreasen Research Topics

Disease

25Neoplasms (Cancer)
01/2019 - 06/2002
7Neoplasm Metastasis (Metastasis)
01/2019 - 03/2004
4Carcinoma (Carcinomatosis)
09/2011 - 05/2003
3Breast Neoplasms (Breast Cancer)
01/2019 - 05/2003
3Autolysis
01/2013 - 02/2009
2Sepsis (Septicemia)
10/2020 - 01/2008
2Thrombosis (Thrombus)
10/2020 - 03/2016
2Hemorrhage
10/2020 - 01/2017
2Inflammation (Inflammations)
10/2020 - 01/2016
2Disseminated Intravascular Coagulation
10/2020 - 01/2008
2Ischemic Stroke
03/2016 - 07/2015
2Cardiovascular Diseases (Cardiovascular Disease)
09/2008 - 08/2003
2Squamous Cell Carcinoma of Head and Neck
03/2008 - 09/2005
1Infections
10/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
07/2016
1Carcinogenesis
03/2016
1Myocardial Infarction
03/2016
1Pulmonary Embolism
03/2016
1Skin Diseases (Skin Disease)
03/2015
1Lymphatic Metastasis
03/2008
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2007
1Colonic Neoplasms (Colon Cancer)
08/2004
1Adenocarcinoma
08/2004
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2003

Drug/Important Bio-Agent (IBA)

10Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2019 - 03/2004
10Plasminogen Activators (Plasminogen Activator)IBA
03/2011 - 06/2002
9Plasminogen Activator Inhibitor 1IBA
08/2011 - 11/2003
5SerpinsIBA
01/2016 - 08/2003
4Serine Proteases (Serine Protease)IBA
03/2016 - 12/2012
4PlasminogenIBA
03/2016 - 05/2003
4Peptide Hydrolases (Proteases)FDA Link
03/2015 - 07/2007
4Messenger RNA (mRNA)IBA
06/2010 - 05/2003
3FibrinolysinFDA Link
03/2016 - 10/2009
3AntibodiesIBA
08/2011 - 11/2003
2Tissue Plasminogen Activator (Alteplase)FDA Link
03/2016 - 07/2015
2Enzyme Precursors (Zymogens)IBA
03/2016 - 02/2009
2Peptide LibraryIBA
10/2011 - 06/2008
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
10/2011 - 09/2011
2EpitopesIBA
08/2011 - 02/2009
2Proteins (Proteins, Gene)FDA Link
03/2008 - 09/2007
2Biomarkers (Surrogate Marker)IBA
09/2007 - 11/2003
1LipopolysaccharidesIBA
10/2020
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2020
1Dacarbazine (DIC)FDA LinkGeneric
10/2020
1embelinIBA
10/2020
1AnticoagulantsIBA
10/2020
1Peptides (Polypeptides)IBA
01/2019
1Cyclic PeptidesIBA
01/2019
1trypsin-like serine proteaseIBA
01/2017
1Lysine (L-Lysine)FDA Link
01/2017
1HGF activatorIBA
07/2016
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
03/2016
1CollagenIBA
03/2016
1Immunoglobulin FragmentsIBA
03/2016
1Fibrinolytic Agents (Antithrombotic Agents)IBA
03/2016
1TrypsinIBA
03/2016
1FibrinIBA
03/2016
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2015
1oxidized low density lipoproteinIBA
07/2015
1ElementsIBA
01/2013
1matrigelIBA
12/2012
1Aprotinin (Trasylol)FDA Link
09/2011
1Monoclonal AntibodiesIBA
08/2011
1hydrogen sulfite (bisulfite)IBA
06/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2009
1Protein CIBA
01/2008
1Factor VII (Proconvertin)IBA
07/2007
1RNA (Ribonucleic Acid)IBA
07/2007
1Plasminogen InactivatorsIBA
03/2004
1ParaffinIBA
11/2003
1Formaldehyde (Formol)FDA Link
11/2003
1XR 5118IBA
08/2003
1Glycoproteins (Glycoprotein)IBA
05/2003
1VitronectinIBA
05/2003
1IntegrinsIBA
05/2003

Therapy/Procedure

4Therapeutics
10/2007 - 06/2002